Is this the best insurance stock you’ve never heard of?

Could this insurance stock be a better buy than the usual blue-chip suspects?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Investors are spoilt for choice when it comes to FTSE 100 insurance stocks. With no fewer than eight multi-billion-pound household names to choose from — including Prudential, Aviva and Legal & General (LSE: LGEN) — is there any reason for investors to look beyond the blue-chip index?

In particular, why would a £530m small cap that you’ve probably never heard of be worthy of consideration?

Dividend machine

The company in question is life insurance group Chesnara (LSE: CSN), which was spun out of Countrywide estate agency in 2004. The company released its latest annual results today, reporting “one of the busiest and most successful years” in its history, with growth across all three of its territories (UK, Sweden and Netherlands).

Net asset value at the year-end stood at £394m, while embedded/economic value (a better reference point for the intrinsic value of the business) was £603m. The latter has grown 379% from £126m in 2004, as the group has expanded with canny acquisitions.

Over the same period, investors have seen a 253% rise in the value of their shares. On top of that, dividends have increased every year — an impressive feat considering the period includes the 2008/9 financial crisis when many financials slashed their payouts. In fact, Chesnara’s dividend record has been so strong that if you’d invested £1,000 in 2004, you’d have now received over £2,000 in dividends.

At a current share price of 353p, Chesnara’s trailing price-to-earnings (P/E) ratio is 12.8 and the dividend yield is 5.5%. Its latest acquisition — Legal & General Nederland — is set to complete next week and the company has considerable scope for further growth. The attractive earnings rating, dividend yield and growth prospects lead me to rate the shares a ‘buy’.

Trade off

Blue-chip Legal & General has disposed of a number of its non-core operations since the financial crisis and the sale of its Dutch business to Chesnara comes into that category. L&G is a stronger, more focused group these days but how does it compare with Chesnara?

Let’s have a look first at the historical record of L&G over the 17-year period in which Chesnara has been in existence.

The FTSE 100 firm’s shareholders have seen a 173% rise in the value of their shares compared with the 253% enjoyed by their counterparts at Chesnara. L&G cut its dividend during the financial crisis and although it recovered strongly, the total paid out since 2004, while very decent, nevertheless falls well below that of its impressive smaller rival. L&G has paid out just over £1,000 on an investment of £1,000 compared with Chesnara’s payout of just over £2,000.

What of current valuations? At a share price of 246p, L&G is on a trailing P/E of 11.1 (compared with Chesnara’s 12.8) and a dividend yield of 5.8% (compared with Chesnara’s 5.5%). While L&G’s long-term historical return doesn’t match the small cap’s, I believe it’s also an attractive investment today, due to its blue-chip status, lower earnings rating and higher yield.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »